Cytosorbents Launches Webinar on Sepsis Treatment with CytoSorb® Insights for Healthcare Professionals

Cytosorbents Launches Educational Initiative on Sepsis Treatment

Cytosorbents Corporation, a prominent player in blood purification therapies, announces an upcoming global webinar focused on the critical condition of sepsis and septic shock. Scheduled for September 10, 2025, at 11 AM EDT, the event coincides with Sepsis Awareness Month and World Sepsis Day. The webinar, titled "Turning the Tide in Sepsis and Septic Shock: Real World Insights with CytoSorb," aims to raise awareness of sepsis while showcasing the effectiveness of CytoSorb® as a vital treatment option. Dr. Phillip Chan, CEO of Cytosorbents, will host the session, which features a panel of esteemed international experts to discuss real-world applications and clinical insights regarding the use of CytoSorb in critical care settings.

The webinar is designed to provide healthcare professionals with valuable knowledge about the management of sepsis through CytoSorb. Notable panelists, including Dr. Tobias Hübner from Switzerland, Prof. Zsolt Molnár from Hungary, and Dr. Kevin Pilarczyk from Germany, will share their experiences and best practices concerning the integration of CytoSorb into treatment protocols. The agenda highlights the current understanding of how CytoSorb complements antibiotic treatments, addressing the severe infections associated with sepsis. By emphasizing the synergy between these therapies, the discussion seeks to improve patient outcomes and elucidate the role of innovative blood purification methods in critical care.

In addition to raising awareness, the webinar serves as an essential platform for healthcare professionals who wish to deepen their understanding of advanced treatment strategies for sepsis. With sepsis being one of the leading causes of mortality in intensive care units, the insights shared during the event could prove invaluable for clinicians striving to enhance patient care. Attendees can register online, making this event accessible to a global audience and providing a unique opportunity to learn from frontline experts in the field.

The initiative aligns with Cytosorbents' ongoing commitment to advancing treatment options for critical medical conditions. By actively engaging with the medical community and disseminating knowledge, Cytosorbents reinforces its position as a leader in blood purification therapies. As sepsis remains a significant challenge in healthcare, the company’s efforts to educate and inform practitioners emphasize the importance of innovative solutions in improving patient survival rates and quality of care.